RadAlliance Therapeutics, Inc
1 clinical trials · Sponsor
◉ Watch RadAlliance Therapeutics, Inc
| Record | Firm | Date |
|---|---|---|
| Safety and Preliminary Diagnostic Performance of [⁶⁴Cu]Cu-RAX301 in Prostate Cancer (NCT07765940) | RadAlliance Therapeutics, Inc | 2026-09-15 |
Track RadAlliance Therapeutics, Inc automatically
Every clearance here is in the API, with alerts when new ones post.